Report Store Market Intelligence

KOL Perspectives: BTK Inhibitors in RA

Summary

This KOL Insight briefing focuses on KOLs views of BTK Inhibitors in RA.

Questions topics -
- Awareness and potential of BTK inhibitors in RA
- Perceptions of BMS-986142’s Phase IItrial design
- Impact of poseltinib discontinuation on existing perception of BTK inhibitors in RA

Key Highlights

- Of the named BTK inhibitors, KOLs demonstrated the greatest awareness of BMS-986142, despite its lack of Phase II data
- KOLs were divided over BMS-986

Read More